Exxon Mobil Stock Sets New All-Time High

Exxon Mobil Corporation (NYSE: XOM) shares set a new all-time high Thursday. Here's a look at what to know.

Exxon Mobil Corporation (NYSE:XOM) shares set a new all-time high Thursday. Here's a look at what to know.

What To Know:

Exxon Mobil shares reached a new all-time high of $120.70 on Thursday and continue to trade around the $120 mark as the price of crude oil continues its recent rally. 

Crude oil is currently trading above $92 per barrel and climbed over $95 per barrel on Wednesday for the first time in over a year. 

As the price of oil continues to rise, some analysts updated their coverage and price targets on XOM earlier this week:

  • Mizuho analyst Nitin Kumar reiterated Exxon Mobil with a Buy and maintained a $139 price target.
  • Morgan Stanley analyst Devin McDermott maintained Exxon Mobil with a rating of Overweight and raised the price target from $124 to $131.

Related News: What's Going On With Palantir Technologies Stock? 

XOM Price Action: According to Benzinga Pro, Exxon Mobil Corporation shares are  down 0.1% at $120.00 at the time of publication.

Image: David Roumanetf rom Pixabay

Total
0
Shares
Related Posts
Read More

Melinta Therapeutics & Cidara Therapeutics Announce Publication Of Pooled Data From Phase 3 Pivotal ReSTORE Trial & Phase 2 STRIVE Trial Of REZZAYO For The Treatment Of Candidemia & Invasive Candidiasis In The Lancet ID

Publication reaffirms the proven efficacy and safety of rezafungin dosed once-weekly versus a current standard of care echinocandin dosed once-dailyMelinta Therapeutics, LLC and Cidara Therapeutics, Inc. (NASDAQ:CDTX)

CDTX

Read More

Medtronic Presented Late-Breaking Data Showing Performance Of Its OmniaSecure Defibrillation Lead Met Its Primary Safety And Effectiveness Endpoints, Exceeding Prespecified Performance Goals, In The Global LEADR Pivotal Trial

Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart RhythmDUBLIN and BOSTON, May 17, 2024 /PRNewswire/ -- Medtronic plc

MDT